**Question:** Which of the following associated with the highest cardiac mortality?

A. Beta-blockers
B. Angiotensin-converting enzyme inhibitors (ACEIs)
C. Calcium channel blockers (CCBs)
D. Diuretics

**Core Concept:** Cardiac mortality refers to the risk of death due to cardiac-related causes. In this context, we are considering drugs with the potential to improve cardiovascular outcomes and reduce the risk of heart-related deaths.

**Why the Correct Answer is Right:** ACEIs (Angiotensin-converting enzyme inhibitors) are a class of medications typically used to treat hypertension, heart failure, and post-myocardial infarction conditions. They work by inhibiting the Angiotensin-converting enzyme (ACE), which leads to reduced angiotensin II levels. Angiotensin II is a potent vasoconstrictor and aldosterone-stimulating agent that contributes to increased vascular resistance, cardiac hypertrophy, and myocardial ischemia. By blocking ACE, ACEIs help to lower blood pressure, reduce myocardial hypertrophy, and prevent post-myocardial infarction complications, thus reducing cardiac mortality.

**Why Each Wrong Option is Incorrect:**

A. Beta-blockers (e.g., atenolol, metoprolol) are used to treat hypertension, angina, and heart failure. They work by blocking beta-1 receptors in the heart, reducing heart rate and contractility, and lowering blood pressure. While beta-blockers can improve cardiovascular outcomes, they do not have the same level of impact on reducing cardiac mortality as ACEIs.

B. Diuretics (e.g., furosemide, spironolactone) are primarily used for the management of congestive heart failure and edema. They facilitate diuresis, reducing preload and afterload, and improving cardiac function. Diuretics do not directly impact cardiac mortality, unlike ACEIs.

C. Calcium channel blockers (CCBs) are a class of medications that reduce myocardial oxygen demand and improve myocardial oxygen supply. They act by blocking calcium influx into cardiac and smooth muscle cells, leading to vasodilation, reduced myocardial oxygen demand, and improved cardiac function. CCBs have a moderate impact on reducing cardiac mortality compared to ACEIs.

**Clinical Pearl:** The choice of medication depends on the clinical context and patient needs. ACEIs are preferred over other medications for reducing cardiac mortality in certain conditions, such as post-myocardial infarction or heart failure. However, diuretics and CCBs have specific indications in managing hypertension and angina, respectively, and may contribute to overall cardiovascular benefits.

**Why Beta-blockers are less effective in reducing cardiac mortality:**

Beta-blockers are primarily focused on reducing heart rate and contractility, thereby reducing oxygen demand in ischemic heart disease patients. However, their effects on improving myocardial oxygen supply are less pronounced compared to ACEIs, which directly impact myocardial oxygen supply by inhibiting the renin-angiotensin-aldosterone system, reducing myocardial ischemia and improving cardiac function.

The correct answer is ACE inhibitors (ACEIs) due to their direct impact on the renin-